Since 1938 Radionics has been improving the future of medical technology by producing innovative surgical devices. Radionics has become a world leader in the fields of neurosurgery and radiation therapy by combining technical innovation with clinical experience.

Our team of professional caring employees continues our mission of assisting in the treatment of cancer and other disease by developing innovative and superior products together with our customers. We strive to be at the forefront of the medical community as providers of the ultimate in trusted accuracy.

In March 2006 Radionics became part of Integra LifeSciences Corporation. This merger ensures that Radionics will continue to be a worldwide leader in the medical industry by focusing on rapid growth through well-funded research and development, intense marketing efforts, and enhanced customer service.

Our products are used in thousands of procedures every day and are world-renowned for their functionality and high quality. These products include:

• The CRW™ stereotactic surgery system for accurate and precise brain biopsies and electrode placement.
• The CUSA EXcel™ ultrasonic surgery system for tumor removal and other surgical procedures.
• The OmniSight™ EXcel image guided surgery system for interactive computer guidance during surgery.
• The XKnife™ stereotactic radiosurgery and radiotherapy system for irradiation of tumors and arteriovenous malformations.
• The Radionics technical support group for real-time expert troubleshooting and advice.

Our products incorporate advanced technology which is developed by our in-house team of scientists and engineers. Radionics holds over 175 patents in the fields of stereotaxy, ultrasonic surgery, image guidance, and stereotactic radiation therapy. Radionics has attained a leadership position in these fields based on superior engineering, manufacturing, and quality assurance. Radionics is proud of its ongoing leading-edge research and development.